Download presentation
Presentation is loading. Please wait.
2
Contemporary Atrial Fibrillation Management
Morhaf Ibrahim, MD. FHRS
3
Nothing to Disclose
4
Outline Epidemiology Signs and Symptoms Etiology
Differential Diagnosis Diagnostic Tests Classification Management
5
Epidemiology Most frequently diagnosed arrhythmia
Affects 2.3 million people in the US Affects 1/136 people in the US Incidence increases with age
6
Signs and Symptoms Palpitations Weakness Dizziness
Reduced exercise capacity Dyspnea Asymptomatic
7
Etiology/Risk Factors
Structural heart disease Chronic lung disease Pneumonia Hyperthyroidism Alcohol use Pulmonary embolism HTN Pericarditis Key Point MI is a very rare cause of Afib!
8
Differential Diagnosis
Narrow Complex Tachycardias Atrial Fibrillation Atrial Flutter AVNRT AVRT Atrial tachycardia Sinus tachycardia Multifocal atrial tachycardia
9
Classification Paroxysmal: terminates in < 7 days
Persistent: fails to terminate within 7 days Long lasting persistent: > 1 year Lone: Individuals without structural heart disease, < 60 yrs old
10
Diagnostic Testing: EKG
11
Diagnostic Testing: TTE
To assess for structural heart disease LVEF Wall motion Dilation/Hypertrophy Size of right and left atrium Valvular disease Pericardial disease
12
Chest X-Ray Look for emphasema/COPD Cardiac borders Pneumonia
13
Management Rate Control Rhythm Control Anticoagulation
14
Rate Control Why is rate control important? Goals
Long term: Cardiomyopathy Goals Rest HR < 80 bpm 24 Hour (Tele/Holter) < 100 bpm average HR < 110 in 6 minute walk RACE II trial (NEJM 2010)
15
Rate Control (con’t) Medications Metoprolol / Esmolol: IV or Oral
Diltiazem: IV or Oral Verapamil: Oral Only Digoxin: Patients with hypotension Amiodarone: Also for rhythm control
16
Rhythm Control Indications Symptoms of a-fib Personal preference
17
Rhythm Control (con’t)
Synchronized DC cardioversion Emergencies/Hemodynamic instability Greater efficacy than medications Pharmacologic cardioversion Dofetilide, flecainide, ibutilide, propaferone or amiodarone
18
Rate or Rhythm Control? Affirm Study (NEJM 2002): Rate versus rhythm control No difference in incidence of stroke Trend towards lower mortality in the rate control group Afib ablation
19
Anticoagulation and Cardioversion
Afib < 48 hours: Cardioversion (CV) No indication for TEE Afib > 48 hours: Anticoagulate for 3 weeks before CV OR get TEE Anticoagulate for 1 month after CV regardless of CHADSVASC score
20
Anticoagulation – Long Term
21
Key Points MI is a rare CAUSE of a-fib
Rate control must be achieved during exercise, not just at rest Not every patients needs to bridge with heparin Unstable patients should immediately be cardioverted
22
Atrial Fibrillation Ablation
25
Left Atrium Posterior Basal View
R. pulmonary artery L. pulmonary artery R. superior pulmonary vein L. auricle L. superior pulmonary vein L. atrium R. inferior pulmonary vein Olshansky via Medtronic (modified) ____ Demonstrates the anatomy of the left atrium, especially of the pulmonary veins. These can be sites of origin of not only left atrial tachycardias, but also of AF. L. inferior pulmonary vein Coronary sinus Netter F. Atlas of Human Anatomy. 1989;Plate 202.
26
Left Atrium, Posterior Wall
Variable Anatomy (Common) SVC RAA LAA RSPV LSPV LIPV RIPV IVC Nathan, Circ Res, 1969
27
Left Atrium, Posterior Wall Pulmonary Vein Isolation
Nathan, Circ Res, 1969?
28
Atrial Fibrillation Ablation Technique
Combined Modality Imaging Fluoroscopy and now fluoroless 3-D electroanatomic mapping Intracardiac echo
29
Left Atrial Mapping and Catheter Ablation Visualization: Intracardiac Ultrasound
Tenting of the intra-atrial septum during transeptal catheterization An 8 Fr model also was announced in June 2004 (?release date?) Transeptal Access to LA AcuNav 10 Fr Phased Array Diagnostic Ultrasound Catheter (by Acuson)
30
New technology:
31
PV Isolation by RF Lesion
Before …
32
Electronically Isolated PV
After …
33
SUMMARY Atrial Fibrillation Ablation
FOR WHOM? (Paroxysmal or Persistent) AF w/ “significant symptoms” associated Refractory to AADs First line thrapy for certain pts HOW? Electrical isolation of pulmonary veins Atrial tissue substrate modification Accomplished via catheter ablation/cryo balloon combined w/ multiple imaging modalities
34
Actual Afib Ablation Cases
48
Questions ?
49
Thank You !
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.